RMS

bio.nomics – Insights for Managing Mortality Risk   |   London, March 12, 2013

• Insights for Managing Mortality Risk

  Peter Ulrich, Senior Vice President, RMS LifeRisks

• A Tale of Two Babies: How Medical Science, Demographics and Economics Influence Life and Death

  Maura Sullivan, Senior Director, Model Development, RMS LifeRisks

• Time of Death: Managing the Risk of Seasonality and Temporal Patterns of Mortality

  Mary Chang, Modeler, RMS LifeRisks

• Differentiating Mortality: How Mortality Patterns Differ Between Countries and Segments in the Market

  Christopher Breaux, RMS LifeRisks

• Economic Capital and Portfolio Diversification: Managing Risks of Mortality and Longevity in International Portfolios

  Dr. Chris Hornsby, Longevity Risk Model Manager, RMS LifeRisks

• bio.nomics: Bioscience and the Economics of Life Insurance

  Andrew Coburn, Senior Vice President, RMS LifeRisks

• Models, Risk, and Model Risk

  Jon Palin, Director of Actuarial Sciences, RMS LifeRisks

• Developing a Research Agenda
  (no slides available)

  Panel Discussion

  Peter Nakada, RMS
  Prof David Blake, Cass Business School
  Richard Willets, Friends Life
  Jonathan Hughes, Munich Re UK
  Pretty Sagoo, Deutsche Bank

bio.nomics – Understanding Mortality Risk   |   New York, January 30, 2013

• Life & Longevity Risk Management

  Peter Ulrich, Senior Vice President and Business Lead of RMS LifeRisks

• New Insights into Mortality Risk: Incorporating Projections of Geroscience Advances into Risk Assessment

  Dr. Andrew Coburn, Senior Vice President and Technical Lead of RMS LifeRisks

• The Life-Annuity Offset: Quantifying the Benefits of a Diversified Portfolio

  Dr. Chris Hornsby, Longevity Risk Model Manager, RMS LifeRisks

• What's Really Going on in Pension Risk Transfer?

  Amy Kessler, Senior Vice President and Head of Longevity Reinsurance, Prudential

• Speeding the Development of a Liquid Market for Longevity Risk Transfer
  (no slides available)

  Jeff Mulholland, Managing Director and Head of Insurance and Pension Solutions-Americas, Société Générale

• Making the Case for Scalable Longevity Solutions

  Chris Madsen, Group Vice President, AEGON

• Growing the Biometric Asset Class
  (no slides available)

  Panel Discussion

  Peter Nakada, RMS
  Kevin O' Regan, Partner Re
  Jeff Mulholland, Société Générale
  Chris Madsen, AEGON

Investigating Future Mortality   |   London May 24, 2012

• Life & Longevity Risk Management

  Welcome and Agenda

  Peter Ulrich

• What's New in Medical Science

  From Populations to Molecules Segmenting Mortality Trend Risk

  Maura Sullivan

• Made in the Lab

  New Viruses and their Implications for Pandemic Risk

  Gordon Woo

• Capital Sensitivity

  What Matters in Solvency Risk Capital Assessments

  Chris Ordowich

• The Life and Death Balance

  Mitigating solvency capital requirements through hedging mortality and annuity exposure

  Chris Hornsby

• The Long-Term Rate

  Setting Mortality Improvement Assumptions for Longevity Liabilities

  Andrew Coburn

• Segmenting Mortality Trend Risk

  Differentiating socio-economic differences in future longevity liabilities

  Jon Palin

• RMS LifeRisks 2.0

  Harnessing the power of the cloud for integrated mortality modelling

  Justin Caird

• Getting Deals Done

  Panel discussion on transferring longevity risk

  Peter Nakada